MARC Record from marc_columbia

LEADER: 05421fam a2200421 a 4500
001 4052929
005 20221027024929.0
008 960311t19961996enka b 001 0 eng c
010 $a 96013797
020 $a0471967122 (hbk : alk. paper)
035 $a(OCoLC)34473173
035 $a(OCoLC)ocm34473173
035 $9ALY6644HS
035 $a(NNC)4052929
035 $a4052929
040 $aDNLM/DLC$cDLC$dDLC$dNNC-M$dOrLoB-B
050 00 $aRC271.C5$bM843 1996
060 10 $aQV 269 M961 1996
082 00 $a616.99/4061$220
245 00 $aMultidrug resistance in cancer cells :$bmolecular, biochemical, physiological, and biological aspects /$cedited by Sudhir Gupta and Takashi Tsuruo.
260 $aChichester ;$aNew York :$bWiley,$c[1996], ©1996.
300 $axii, 507 pages :$billustrations ;$c26 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $g1.$tCloning and Structure: Function Analysis of the Mouse mdr Gene Family /$rMaya Hanna and Philippe Gros --$g2.$tFunctional and Molecular Characterization of the Human Multidrug Transporter /$rChristine A. Hrycyna, Shudong Zhang, Muralidhara Ramachandra, Baofu Ni, Ira Pastan and Michael M. Gottesman --$g3.$tRegulation of MDR Genes /$rMarilyn M. Cornwell --$g4.$tCytogenetic Manifestations of Multidrug Resistance /$rJune L. Biedler and Barbara A. Spengler --$g5.$tChromosomal and Extrachromosomal Localization of Human MDR Genes /$rPatricia V. Schoenlein --$g6.$tMRP, Mode of Action and Role in MDR /$rGuido J. R. Zaman and Piet Borst --$g7.$tRole of LRP/Major Vault Protein in Multidrug Resistance /$rRik J. S. Scheper, George L. Scheffer, Marcel J. Flens, Paul van der Valk, Chris J. L. M. Meijer, Herbert M. Pinedo, Hans C. Clevers, Marilyn L. Slovak, Leonard H. Rome, Robert H. Shoemaker and Miguel A. Izquierdo --
505 80 $g8.$tDNA Topoisomerase I Inhibitors and Multidrug Resistance /$rYves Pommier, Akira Fujimori, Yuko Hoki, Malini Gupta and Marzia Gariboldi --$g9.$tThe Role of Topoisomerase II in Multidrug Resistance /$rShigeru Yamada and Koichi Ando --$g10.$tGlutathione and Glutathione-associated Enzymes in Multidrug Resistance /$rLinda R. Barone and Kenneth D. Tew --$g11.$tOncogenes and Tumor Suppressor Genes in Multidrug Resistance /$rTatyana N. Ignatova and William T. Beck --$g12.$tDrug Sensitivity Genes: Identification and Analysis Using the Genetic Suppressor Element Approach /$rAndrei V. Gudkov --$g13.$tChanges in Membrane Ionic Conductances Associated with Multidrug Resistance /$rKeisuke Kouyama, Anthony C. Chao and Phyllis Gardner --$g14.$tIdentification and Characterization of the Drug-binding Sites of P-glycoprotein /$rAhmad R. Safa --$g15.$tPhosphorylation of Proteins Involved in Multidrug Resistance /$rTimothy C. Chambers --$g16.$tProtein Kinase C and its Isozymes in Multidrug Resistance /$rSudhir Gupta --
505 80 $g17.$tNon-PKC Kinases and Multidrug Resistance /$rIrene Abraham --$g18.$tP-glycoprotein Expression in Normal Human Tissues /$rJames P. O'Brien and Carlos Cordon-Cardo --$g19.$tP-glycoprotein in the Normal Hematopoietic Progenitors and Cells of the Immune System /$rSudhir Gupta --$g20.$tRole of P-glycoprotein in the Transport of Hormones and Peptides /$rKazumitsu Ueda, Kouichi Kino, Yoshitomo Taguchi, Kouji Yamada, Tohru Saeki, Yusuke Tanigawara and Tohru Komano --$g21.$tRole of P-glycoprotein in the Blood-Brain Barrier /$rMikihiko Naito and Takashi Tsuruo --$g22.$tTransport of P-glycoprotein-modifying Agents by P-glycoprotein /$rKeisuke Yusa, Mikihiko Naito and Takashi Tsuruo --$g23.$tMice with Disrupted P-glycoprotein Genes /$rPiet Borst and A. H. Schinkel --$g24.$tMolecular Pharmacology of Reversal of Multidrug Resistance and its Clinical Implications /$rEllen Friche and William T. Beck --$g25.$tMultidrug Resistance-reversing Agents for Potential Clinical Use /$rOsamu Nakanishi and Takashi Tsuruo --
505 80 $g26.$tCyclosporins and Related Fungal Products in the Reversal of P-glycoprotein-mediated Multidrug Resistance /$rFrancis Loor --$g27.$tOligonucleotide Modulation of Multidrug Resistance Gene Expression /$rTsukasa Ohkawa, Hiroshi Kijima, Akira Irie, George Horng, Anna Kaminski, Jerry Tsai, Brandon I. Kashfian and Kevin J. Scanlon --$g28.$tApplication of the MDR1 Gene for Human Gene Therapy /$rYoshizaku Sugimoto, Takashi Tsuruo, Ira Pastan and Michael M. Gottesman --$g29.$tReversal of MDR in Acute Leukemia and Non-Hodgkin's Lymphoma /$rWilliam S. Dalton --$g30.$tPrognostic Significance and Reversal of MDR in Multiple Myeloma /$rPieter Sonneveld --$g31.$tReversal of MDR in Solid Tumors /$rGiuseppe Giaccone and Herbert M. Pinedo.
650 0 $aDrug resistance in cancer cells.$0http://id.loc.gov/authorities/subjects/sh90005205
650 0 $aMultidrug resistance.$0http://id.loc.gov/authorities/subjects/sh90005206
650 12 $aDrug Resistance, Neoplasm.$0https://id.nlm.nih.gov/mesh/D019008
650 12 $aDrug Resistance, Multiple$xphysiology.$0https://id.nlm.nih.gov/mesh/D018432Q000502
650 22 $aCarrier Proteins$xphysiology.$0https://id.nlm.nih.gov/mesh/D002352Q000502
650 22 $aTumor Cells, Cultured.$0https://id.nlm.nih.gov/mesh/D014407
700 1 $aGupta, Sudhir.$0http://id.loc.gov/authorities/names/n79018225
700 1 $aTsuruo, Takashi.$0http://id.loc.gov/authorities/names/n89143357
852 00 $boff,hsl$hRC271.C5$iM843 1996